| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 04/28/2004 | EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 04/28/2004 | EP1412326A1 Butyric acid derivatives |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them |
| 04/28/2004 | CN1492862A Preparation of warfarin sodium from warfarin acid |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1491929A Diether used in preparing ziegler-Natta catalyst |
| 04/28/2004 | CN1147455C Green extraction process of high-purity tea polyphenol |
| 04/28/2004 | CN1147298C Prevention and curing agent for hepatitis C |
| 04/28/2004 | CN1147297C Novel aesculetin derivatives and pharmaceutical composition |
| 04/28/2004 | CN1147243C Method for processing Hericium erinaceus |
| 04/27/2004 | US6727277 Benzo(a)xanthene derivatives; lymphatic absorption intensifiers 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6726972 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer |
| 04/27/2004 | CA2140368C (3r,4r)-.delta.6-tetrahydrocannabinol-7-oic acids |
| 04/27/2004 | CA2118929C (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
| 04/22/2004 | WO2004033448A2 Isolation, purification and synthesis of procyanidin b2 and uses thereof |
| 04/22/2004 | WO2004033397A2 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | WO2004033390A2 Methods of preparing tocopherol compound salts in supercritical media |
| 04/22/2004 | WO2004005243A3 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 04/22/2004 | WO2003070159A3 Novel coumarin and chromene compounds and methods of treating or preventing viral infections |
| 04/22/2004 | WO2003061563A3 Method of preparing delta-9 tetrahydrocannabinol |
| 04/22/2004 | US20040077882 Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
| 04/22/2004 | US20040077864 A ketoxime of given formula, palladium as a reduction and racemization catalyst, lipase as a stereoselective acylation catalyst, an acyl donor, and a tertiary amine react in an organic solvent to provide a chiral amide which is hydrolyzed |
| 04/22/2004 | US20040077721 Administering retinoid compound; skin disorders, solar radiation damage; antiproliferative agents |
| 04/22/2004 | US20040077711 4-(2-Aminoethylthio)epicatechine derivatives as anticarcinogenic agents; cardiovascular diseases and aging resistance |
| 04/22/2004 | US20040077529 Agonists; fused bicyclic systems substituted with aromatic group and aminoalkyl group |
| 04/22/2004 | CA2501831A1 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | CA2421887A1 Baicalein and baicalein analogs and uses thereof |
| 04/21/2004 | EP1409563A1 Photoactive materials |
| 04/21/2004 | EP1409516A2 Aromatic sulfenates for type i phototherapy |
| 04/21/2004 | EP1409474A1 Method for the production of dronabinol |
| 04/21/2004 | EP1409473A2 CONVERSION OF CBD TO $g(D)?8 -THC AND $g(D)?9 -THC |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1408976A1 Treatment for attention-deficit hyperactivity disorder |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491106A Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/21/2004 | CN1490321A Effective parts of fructus sophorae flavone production and use thereof |
| 04/21/2004 | CN1146554C Enantioeletive synthesis of nonsteroidal antiestrogen |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/20/2004 | US6723859 Chromene compound |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/15/2004 | WO2004031165A1 Remedies |
| 04/15/2004 | WO2004030683A1 Remedies |
| 04/15/2004 | WO2004030440A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 04/15/2004 | WO2003080778A3 Methods for treating deodorizer distillate |
| 04/15/2004 | US20040073033 Process for the preparation of phenylalanine enamide derivatives |
| 04/15/2004 | US20040073014 Fluorescent dyes, energy transfer couples and methods |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072843 Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 04/15/2004 | US20040072828 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 04/15/2004 | US20040072209 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 04/15/2004 | CA2501017A1 Remedies |
| 04/15/2004 | CA2500527A1 Remedies |
| 04/15/2004 | CA2500056A1 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 04/14/2004 | EP1408090A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 04/14/2004 | EP1407036A1 "flavonoid concentrates" |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 04/14/2004 | CN1488638A Barrenwort total falvone extracting method and product made from said extract |
| 04/14/2004 | CN1145622C Substitated benzo heterocyclic compounds, process for their preparation and pharmaceutical compositions containing same |
| 04/13/2004 | US6720432 Synthesis of epecatechin-4α, 8-epicatechin dimers and derivatives thereof |
| 04/13/2004 | US6720353 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units |
| 04/13/2004 | US6719926 Chromene compound |
| 04/13/2004 | CA2147123C Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/08/2004 | WO2004029579A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 04/08/2004 | WO2004029578A2 Energy transfer dyes, terminators and use thereof |
| 04/08/2004 | WO2004029028A2 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides as dyestuffs |
| 04/08/2004 | WO2003031430A3 Flavonoid compounds and their pharmaceutical uses |
| 04/08/2004 | US20040068003 Compounds useful for the inhibition of ALDH |
| 04/08/2004 | US20040068002 4-aminobenzopyran derivatives |
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067894 Preparation having antioxidant properties |
| 04/07/2004 | EP1404662A2 Process for preparing isocoumarins |
| 04/07/2004 | EP1404314A1 Aerosol formulations of delta 8 tetrahydrocannabinol |
| 04/07/2004 | EP1214307B1 4-oxybenzopyran derivative |
| 04/07/2004 | EP0817781B1 Alkali metal formononetin and method of mycorrhizal stimulation |
| 04/07/2004 | CN1487934A 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 04/06/2004 | US6716998 Such as (2r)-3,4-dihydro-2h-chromen-2-yl-methyl-4-methyl-benzenesulfonate; metathesis ring closing polymerization |
| 04/06/2004 | US6716996 Process for preparing substituted coumarins |
| 04/06/2004 | US6716873 Tocopherol ester compounds |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716832 Arylphenyl-substituted cyclic ketoenols |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | CA2223927C Detection of transmembrane potentials by optical methods |
| 04/06/2004 | CA2104114C Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
| 04/01/2004 | WO2004026857A2 Methods of purifying cannabinoids from plant material |
| 04/01/2004 | WO2004026856A1 Tocopheryl ester |
| 04/01/2004 | WO2003099780A3 Luminogenic protease substrates |
| 04/01/2004 | WO2003079998A3 Treatment of diseases involving defective gap junctional communication |
| 04/01/2004 | WO2003059874A3 Aromatic thioether liver x-receptor modulators |
| 04/01/2004 | WO2003028652A3 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |